STOCK TITAN

Cohen Milstein Reminds Paragon 28, Inc. Investors of Nov. 29, 2024 Lead Plaintiff Deadline

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Negative)
Tags

Cohen Milstein has announced a securities class action lawsuit against Paragon 28 (NYSE:FNA), a medical device company, regarding alleged false and misleading statements about financial statements and internal controls. The lawsuit covers investors who purchased shares between May 5, 2023, and September 20, 2024. Investors who suffered significant losses during this period have until November 29, 2024, to request appointment as lead plaintiff. The complaint, filed in the U.S. District Court for the District of Colorado, alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by current and former officers.

Cohen Milstein ha annunciato una causa collettiva per valori mobiliari contro Paragon 28 (NYSE:FNA), una società di dispositivi medici, riguardo presunti dichiarazioni false e fuorvianti relative ai bilanci finanziari e ai controlli interni. La causa riguarda gli investitori che hanno acquistato azioni tra il 5 maggio 2023 e il 20 settembre 2024. Gli investitori che hanno subito perdite significative durante questo periodo hanno tempo fino al 29 novembre 2024 per richiedere la nomina come attore principale. Il reclamo, depositato presso il Tribunale Distrettuale degli Stati Uniti per il Distretto del Colorado, sostiene violazioni delle Sezioni 10(b) e 20(a) del Securities Exchange Act del 1934 da parte di funzionari attuali e passati.

Cohen Milstein ha anunciado una demanda colectiva de valores mobiliarios contra Paragon 28 (NYSE:FNA), una empresa de dispositivos médicos, por declaraciones supuestamente falsas y engañosas sobre los estados financieros y los controles internos. La demanda cubre a los inversores que compraron acciones entre el 5 de mayo de 2023 y el 20 de septiembre de 2024. Los inversores que sufrieron pérdidas significativas durante este período tienen plazo hasta el 29 de noviembre de 2024 para solicitar ser nombrados demandantes principales. La queja, presentada en el Tribunal de Distrito de EE. UU. para el Distrito de Colorado, alega violaciones de las Secciones 10(b) y 20(a) de la Ley de Valores de 1934 por parte de funcionarios actuales y anteriores.

Cohen MilsteinParagon 28 (NYSE:FNA)라는 의료기기 회사에 대해 재무제표 및 내부 통제에 대한 잘못된 진술과 오해의 소지가 있는 진술에 관한 증권 집단 소송을 발표했습니다. 이 소송은 2023년 5월 5일부터 2024년 9월 20일 사이에 주식을 구매한 투자자를 포함합니다. 이 기간 동안 상당한 손실을 입은 투자자는 2024년 11월 29일까지 원고 주임으로 지목해달라고 요청할 수 있습니다. 이 고소장은 콜로라도 지구의 미국 지방법원에 제출되었으며, 현재 및 이전 임원들이 1934년 증권거래법10(b)20(a)조를 위반했다고 주장하고 있습니다.

Cohen Milstein a annoncé une action en justice collective concernant des valeurs mobilières contre Paragon 28 (NYSE:FNA), une entreprise de dispositifs médicaux, au sujet d'allégations de fausses déclarations et de déclarations trompeuses concernant les états financiers et les contrôles internes. La poursuite couvre les investisseurs qui ont acheté des actions entre le 5 mai 2023 et le 20 septembre 2024. Les investisseurs ayant subi des pertes importantes durant cette période ont jusqu'au 29 novembre 2024 pour demander à être nommés demandeurs principaux. La plainte, déposée dans le tribunal de district des États-Unis pour le district du Colorado, allègue des violations des Sections 10(b) et 20(a) de la Securities Exchange Act de 1934 par des dirigeants actuels et anciens.

Cohen Milstein hat eine Sammelklage gegen Paragon 28 (NYSE:FNA), ein Unternehmen für medizinische Geräte, angekündigt, wegen angeblich falscher und irreführender Aussagen über Finanzberichte und interne Kontrollen. Die Klage betrifft Investoren, die zwischen dem 5. Mai 2023 und dem 20. September 2024 Aktien erworben haben. Investoren, die in diesem Zeitraum erhebliche Verluste erlitten haben, haben bis zum 29. November 2024 Zeit, die Bestellung als Hauptkläger zu beantragen. Die Klage, die beim US-Bezirksgericht für den Bezirk Colorado eingereicht wurde, behauptet, dass gegen die Abschnitte 10(b) und 20(a) des Securities Exchange Act von 1934 durch derzeitige und ehemalige Führungskräfte verstoßen wurde.

Positive
  • None.
Negative
  • Company faces securities class action lawsuit over alleged false financial statements
  • Potential legal liabilities and associated costs from securities fraud allegations
  • Questions raised about internal control effectiveness

Insights

This class action lawsuit against Paragon 28 raises significant concerns about alleged financial statement misrepresentations and internal control issues. The case, filed in Colorado District Court, potentially exposes the company to substantial financial liability and reputational damage. The specified class period of over 16 months (May 2023 to September 2024) suggests systematic issues rather than isolated incidents. Cohen Milstein's track record in securities litigation, particularly their $1 billion recovery in the Wells Fargo case, indicates this is a serious legal challenge. The November 29, 2024 deadline for lead plaintiff designation is important for affected investors who experienced significant losses. The allegations of violations of Sections 10(b) and 20(a) of the Securities Exchange Act could result in material financial penalties and mandatory corporate governance reforms if proven.

WASHINGTON, DC / ACCESSWIRE / November 19, 2024 / Cohen Milstein reminds investors who lost money on securities of Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA) purchased between May 5, 2023 and September 20, 2024 that they can contact Cohen Milstein Sellers & Toll PLLC to learn about a pending securities class action lawsuit.

To learn about your legal options, click here to connect with a member of the Cohen Milstein team or contact Partner Molly J. Bowen at (202) 408-4600 or mbowen@cohenmilstein.com.

BACKGROUND: On October 18, 2024 a complaint against medical device company Paragon 28, Inc. was filed in the U.S. District Court for the District of Colorado. The complaint alleges that certain current and former officers made false and misleading statements to investors about financial statements and internal controls in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

NEXT STEPS: If you suffered a significant loss in Paragon 28 shares purchased during the proposed class period of May 5, 2023 to September 20, 2024, and are interested in serving as lead plaintiff in this action, you have until November 29, 2024 to request that the court appoint you as lead plaintiff. You are not required to file a lead plaintiff motion to share in any recovery in this action as a class member.

OUR FIRM: With more than 100 attorneys in eight offices, Cohen Milstein is one of the largest plaintiff-side law firms in the U.S., with more than four decades of experience litigating securities fraud cases. We have recovered billions of dollars to investors, including $1 billion last year as co-lead counsel in In re Wells Fargo & Company Securities Litigation, and are perennially recognized as one of the best securities practice groups in the country by legal publications such as The National Law Journal, Law360, Chambers USA, and The Legal 500. For more information visit www.cohenmilstein.com.

Prior results do not guarantee a similar outcome. Attorney Advertising.

CONTACT INFORMATION:

Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Telephone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com

SOURCE: Cohen Milstein Sellers & Toll PLLC



View the original press release on accesswire.com

FAQ

What is the deadline for Paragon 28 (FNA) investors to file as lead plaintiff?

Investors have until November 29, 2024, to request appointment as lead plaintiff in the securities class action lawsuit.

What period does the Paragon 28 (FNA) class action lawsuit cover?

The class action covers investors who purchased Paragon 28 shares between May 5, 2023, and September 20, 2024.

What are the allegations against Paragon 28 (FNA) in the lawsuit?

The lawsuit alleges that company officers made false and misleading statements about financial statements and internal controls, violating Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

Where was the Paragon 28 (FNA) securities class action lawsuit filed?

The lawsuit was filed in the U.S. District Court for the District of Colorado on October 18, 2024.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

820.46M
49.80M
40.56%
60.89%
5.39%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD